Danaher Corporation DHR is scheduled to release third-quarter 2025 results on Oct. 21, before market open. The Zacks ...

Danaher Corporation (NYSE:DHR) is one of the Best Forever Stocks to Invest In Now. On October 8, Ed Ridley from Rothschild & ...

Healthcare giant Danaher is gearing up to announce its Q3 results in the upcoming week, and analysts expect its earnings ...

Some of these healthcare stocks seem played out already to you, perhaps. I mean, Merck was up 7% just today. Charitable ...

The stock's rise snapped a five-day losing streak.

It’s a sale. Two months after Abcam launched a strategic review of the company, the British antibody research expert has revealed that it’s being bought by Danaher. Danaher Corporation is picking up ...

Danaher Corporation is undervalued, with strong fundamentals, robust free cash flow, and 12.7% upside. Click here to read why DHR stock is a Buy.

(RTTNews) - Danaher Corp. (DHR) announced a profit for third quarter that decreased from last year but beat the Street estimates. The company's earnings totaled $1.129 billion, or $1.51 per share.

On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue increased by 0.5%, compared to ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund ...

Shares of Danaher Corp. rose 7.37% to $212.88 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.34% to 6,711.20 and the ...

Danaher Corporation reported solid Q2 2023 earnings with revenue of $7.16B (7.6% YoY decline) and EPS of $2.05 (25.7% YoY decline). The company's Danaher Business System (DBS) helped navigate ...